Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.

Alzheimer's disease (AD) is characterized by cognitive decline and memory loss, involving mechanisms such as tau hyperphosphorylation and mitochondrial dysfunction. Increasing evidence suggests that age-related alterations in metabolite levels are crucial for the pathogenesis of AD. Here, we an...

Full description

Saved in:
Bibliographic Details
Main Authors: Gwangho Yoon, Min Kyoung Kam, Young Ho Koh, Chulman Jo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0313507
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850033507207741440
author Gwangho Yoon
Min Kyoung Kam
Young Ho Koh
Chulman Jo
author_facet Gwangho Yoon
Min Kyoung Kam
Young Ho Koh
Chulman Jo
author_sort Gwangho Yoon
collection DOAJ
description Alzheimer's disease (AD) is characterized by cognitive decline and memory loss, involving mechanisms such as tau hyperphosphorylation and mitochondrial dysfunction. Increasing evidence suggests that age-related alterations in metabolite levels are crucial for the pathogenesis of AD. Here, we analyzed serum metabolites from mice of various ages (2, 4, 14, and 21 months old) using mass spectrometry. We identified palmitoyl-L-carnitine as a key metabolite with significantly increased levels in aged mice. In vitro experiments with SH-SY5Y neuronal cells demonstrated that palmitoyl-L-carnitine treatment enhanced tau phosphorylation, increased mitochondrial fission, and elevated intracellular calcium levels. Furthermore, the increased levels of tau phosphorylation were significantly reduced by the inhibition of GSK-3β, CDK5, and calpain, indicating that tau kinases activated by calcium overload are directly involved in the increase of tau phosphorylation. Considering that mitochondrial fission is related to mitochondrial dysfunction, we propose that the elevated level of serum palmitoyl-L-carnitine during aging contributes to AD pathology through these pathways. These findings highlight the significant role of lipid metabolism in neurodegeneration and offer potential therapeutic targets for age-related diseases, including AD.
format Article
id doaj-art-da5060c9c1ce4afab4a568fcc2d288b4
institution DOAJ
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-da5060c9c1ce4afab4a568fcc2d288b42025-08-20T02:58:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011911e031350710.1371/journal.pone.0313507Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.Gwangho YoonMin Kyoung KamYoung Ho KohChulman JoAlzheimer's disease (AD) is characterized by cognitive decline and memory loss, involving mechanisms such as tau hyperphosphorylation and mitochondrial dysfunction. Increasing evidence suggests that age-related alterations in metabolite levels are crucial for the pathogenesis of AD. Here, we analyzed serum metabolites from mice of various ages (2, 4, 14, and 21 months old) using mass spectrometry. We identified palmitoyl-L-carnitine as a key metabolite with significantly increased levels in aged mice. In vitro experiments with SH-SY5Y neuronal cells demonstrated that palmitoyl-L-carnitine treatment enhanced tau phosphorylation, increased mitochondrial fission, and elevated intracellular calcium levels. Furthermore, the increased levels of tau phosphorylation were significantly reduced by the inhibition of GSK-3β, CDK5, and calpain, indicating that tau kinases activated by calcium overload are directly involved in the increase of tau phosphorylation. Considering that mitochondrial fission is related to mitochondrial dysfunction, we propose that the elevated level of serum palmitoyl-L-carnitine during aging contributes to AD pathology through these pathways. These findings highlight the significant role of lipid metabolism in neurodegeneration and offer potential therapeutic targets for age-related diseases, including AD.https://doi.org/10.1371/journal.pone.0313507
spellingShingle Gwangho Yoon
Min Kyoung Kam
Young Ho Koh
Chulman Jo
Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
PLoS ONE
title Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
title_full Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
title_fullStr Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
title_full_unstemmed Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
title_short Palmitoyl-L-carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells.
title_sort palmitoyl l carnitine induces tau phosphorylation and mitochondrial dysfunction in neuronal cells
url https://doi.org/10.1371/journal.pone.0313507
work_keys_str_mv AT gwanghoyoon palmitoyllcarnitineinducestauphosphorylationandmitochondrialdysfunctioninneuronalcells
AT minkyoungkam palmitoyllcarnitineinducestauphosphorylationandmitochondrialdysfunctioninneuronalcells
AT younghokoh palmitoyllcarnitineinducestauphosphorylationandmitochondrialdysfunctioninneuronalcells
AT chulmanjo palmitoyllcarnitineinducestauphosphorylationandmitochondrialdysfunctioninneuronalcells